Add BrightSurf on Google Email

JCI Journals


JCI table of contents: December 1, 2005

In a study published in the Journal of Clinical Investigation, Columbia University researchers discovered that replacing leptin in lean individuals who lost weight restored fat mass and reversed metabolic changes. The findings suggest that therapeutics targeting the leptin signaling pathway may assist in maintaining reduced body weight...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2005

JCI table of contents: November 23 2005

Researchers discovered cross-reactive T cells in patients with infectious mononucleosis, which stimulated excessive lymphocyte proliferation. Meanwhile, selectively killing regulatory T cells improved the efficacy of cancer vaccines by enhancing tumor-specific T cell responses.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 23, 2005

JCI table of contents: December 2005

A study using mouse models found that B. pertussis toxin inhibits neutrophil recruitment, delaying antibody-mediated clearance and allowing repeated infection. Another study identified thrombospondin-1 as a novel mediator of ischemic damage in the kidney, which may be a target for drugs to reduce kidney failure risk.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 17, 2005

JCI table of contents December, 2005

Researchers uncover a new mechanism for post-ischemic arrhythmias, exploring the therapeutic potential of mitochondria-targeting compounds. Leptin signaling is shown to reverse obesity, diabetes, and infertility in mice. FcRn is identified as a promising target for treating autoimmune skin blistering diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 10, 2005

Why children of parents with type 2 diabetes are at risk themselves

Research reveals that offspring of type 2 diabetic parents have reduced mitochondrial content and impaired muscle glucose uptake, increasing their risk of developing insulin resistance and type 2 diabetes. Reduced mitochondrial function can lead to lipid accumulation in muscle cells, further exacerbating the condition.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 10, 2005

JCI table of contents November, 2005

Researchers Phillipe Besnard and colleagues pinpoint CD36 as the sensor for lipid detection in the oral cavity. They show that lingual stimulation of CD36 influences behavioral and digestive physiology. The findings suggest a potential pathway mediating fat taste, which may contribute to obesity risk through feeding dysregulation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 1, 2005

JCI table of contents November, 2005

Researchers pinpoint CD36 as the first candidate for detecting fatty acids in the oral cavity, influencing digestive physiology and potentially increasing obesity risk. The study also reveals an alteration in the fat perception system may impact HIV transmission through human milk.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 20, 2005

JCI table of contents November, 2005

Researchers found that HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions, which is inversely correlated with successful control of HIV. This mechanism may lead to targeted immunotherapies for HIV.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 13, 2005

A new step towards an AIDS vaccine

Researchers identify a key pathway for targeting pDC function in HIV vaccine development. A decrease in blood pDC frequency is observed in chronic HIV infections, correlating with high viral load and reduced CD4 counts.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 13, 2005

A novel mechanism of action for anti-tumor agent, CA4P

Researchers discover that CA4P selectively targets endothelial cells, inducing regression of unstable blood vessels by disrupting VE-cadherin signaling. This breakthrough could lead to new avenues for targeting tumor neo-vessels and increasing the therapeutic window of anti-angiogenic agents.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 6, 2005

JCI table of contents November, 2005

Researchers found that CA4P selectively targets endothelial cells, inducing regression of unstable vessels by disrupting VE-cadherin signaling. This discovery may lead to new avenues for targeting tumor neo-vessels and increasing the therapeutic window of anti-angiogenic agents.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 6, 2005

Mitochondrial biology gets a new chaperone

A study has identified a new molecular chaperone involved in assembling the enzyme complex I of mitochondria. The research found that B17.2L is a key protein required for this process and that it is mutated in patients with progressive encephalopathy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 3, 2005

JCI table of contents October 3, 2005

A new study published in The Journal of Clinical Investigation found that decreased function of the CREB gene transcription factor is involved in anxiety and excessive alcohol drinking behavior. Decreased CREB function was shown to be important for maintaining high anxiety and excessive alcohol drinking. This genetic determinant create...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 3, 2005

JCI table of contents October 1, 2005

Scientists discovered that interleukin-6 increases in TM patients' cerebrospinal fluid and is linked to tissue injury. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXR phosphorylation. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 22, 2005

A cytokine not kind to an injury of the spine

Researchers at Johns Hopkins found elevated IL-6 levels correlate with tissue injury and clinical disability in Transverse Myelitis (TM) patients. Elevated IL-6 levels are necessary and sufficient to mediate neural injury, dependent on nitric oxide.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 22, 2005

JCI table of contents October 1, 2005

Researchers show that CD32 isoforms have differential contributions to dendritic cell activation, with ligation of CD32a inducing maturation and ligation of CD32b inhibiting it. Intravenous immune globulin selectively shifts Fc-gamma receptor expression to a CD32b-dominated profile, explaining its anti-inflammatory properties.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 15, 2005

JCI table of contents October 1, 2005

Researchers found that the fatty acid DHA decreases levels of Abeta peptides associated with Alzheimer disease and upregulates neuroprotectin D1, an endogenous messenger inhibiting apoptosis triggered by these peptides. Additionally, studies revealed beryllium-specific T cells determine immune responses in exposed workers and apoptosis...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 8, 2005

Fatty acids – Good for the brain, good for Alzheimer disease

Research suggests that docosahexaenoic acid (DHA) can decrease levels of pathogenic Abeta peptides associated with Alzheimer's disease in human brain cells. The synthesis of neuroprotectin D1 (NPD1), an endogenous DHA-derived messenger, is also upregulated and inhibits apoptosis triggered by Abeta peptides.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 8, 2005

New bacterial gene provides meningitis mechanism

Researchers identified a novel GBS gene, iagA, that facilitates the bacteria's interaction with host cells by synthesizing a glycolipid anchor. This discovery contributes to understanding the molecular pathogenesis of invasive GBS infection, highlighting the importance of proper cell surface anchoring for bacterial invasion and virulence.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2005

JCI table of contents September 1, 2005

Researchers have discovered a novel Group B Streptococcus (GBS) gene, iagA, that helps the bacteria invade the human blood-brain barrier, leading to meningitis. A glycolipid treatment has been found to induce long-term anergy in natural killer T cells, which could impact its use as an immune activator.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2005

Growing lymph vessels with macrophages? Surprisingly, yes!

Researchers discovered that CD11b-positive macrophages play a crucial role in the development of lymphangiogenesis in the cornea during inflammatory conditions. These macrophages transform into endothelial cells or stimulate the division of existing lymphatic cells, leading to the formation of new lymph vessels.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2005

JCI table of contents September 1, 2005

Researchers have identified the Dido gene as a potential tumor suppressor in myelodysplastic/myeloproliferative diseases. Additionally, SOCS-7 has been found to regulate insulin signaling and enhance insulin action. Furthermore, aldose reductase expression has been linked to accelerated diabetic atherosclerosis in transgenic mice.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 25, 2005

Insulin sensitivity gets a kick out of SOCS-7

The study found that SOCS-7-deficient mice have increased IRS protein levels and prolonged IRS activation, leading to enhanced insulin action and glucose homeostasis. The researchers also observed increased growth of pancreatic islets with elevated fasting insulin levels and hypoglycemia.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 25, 2005

Looking at autoimmune diabetes, literally

Researchers developed a novel MRI strategy to visualize inflammatory lesions in the pancreas that cause type-1 diabetes. This new approach provides preclinical data on mouse models, guiding the application of an in vivo MRI technique to patients with autoimmune diabetes.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 18, 2005

JCI table of contents September 1, 2005

A new BCG vaccine strain protects against tuberculosis with high efficacy, while a novel TWEAK pathway induces liver cell proliferation in response to injury. These findings may lead to specific therapies for liver diseases and improved TB protection.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 18, 2005

Effective Alzheimer treatment: The nose knows

Researchers have developed a new nasal vaccine that decreases Alzheimer's disease (AD) burden in mice by activating microglia to clear beta-amyloid from the brain. The vaccine combines an FDA-approved multiple sclerosis treatment, glatiramer acetate, with a safe and effective nasal adjuvant that has been tested in humans.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 11, 2005

JCI table of contents September 1, 2005

Researchers have solved a 72-year-old mystery surrounding cholesterol production, revealing that Insig proteins play a crucial role in regulating this process. The study found that mice lacking these proteins accumulate excessive cholesterol and fat in the liver, highlighting the importance of Insig in maintaining normal lipid metabolism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 11, 2005

JCI Table of contents August 1, 2005

Researchers investigate Akt1's impact on cardiac function, finding it can enhance cardiac function after heart failure but also contribute to maladaptive effects. A new gene therapy approach successfully treats severe combined immunodeficiency (SCID) in mice, offering promising implications for its treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2005

3 papers present fresh paths to ponder Akt1 in the heart

Recent studies using transgenic mice have shown that overactive Akt1 can lead to cardiac dysfunction and hypertrophy. In contrast, Akt1 is critical for adaptive angiogenesis in the heart after ischemia. The research highlights the importance of understanding Akt1's role in regulating cardiovascular function.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2005

How bacteria break B cell tolerance

Researchers found that bacterial infections can activate self-reactive B cells with significant affinity, driving them to mature into harmful memory B cells. This activation is facilitated by the cooperation of autoantigens, innate immunity, and T cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 21, 2005

JCI table of contents August 1, 2005

Researchers discover hemoglobin's novel function as a nitrite reductase, generating nitric oxide to regulate vasodilation. Separate studies reveal that M cells are not necessary for oral tolerance induction, while bacterial infections can break B cell tolerance by activating self-reactive B cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 21, 2005

Learning how leukemia comes to life

Researchers at Ludwig Maximillians University report that AML1-ETO cooperates with FLT3 to induce rapid and aggressive acute leukemia in mice. This study supports a pathogenetic model of acute leukemia, which requires activating mutations in signal transduction pathways and transcription factors for leukemogenesis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 14, 2005

Why IL-2 works in HIV

Researchers found that intermittent IL-2 administration induces high CD4 and CD8 cell proliferation followed by prolonged CD4 cell survival. This effect helps explain the preferential increase of CD4 cells in patients treated with IL-2 therapy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 14, 2005

DNA meets heart drugs with resistance

Researchers at Vanderbilt University have identified a DNA polymorphism that interferes with the binding of antiarrhythmic drugs to a specific ion channel in the heart. This structural change allows for variable drug access to its target site, leading to increased drug resistance in some individuals.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 14, 2005